Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002664 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-09 | 2023-01-05 | OFIX | Elting Kimberley A. | Pres, Gbl Orthopedics | A - Grant | $0.00 | +79.4K | 152.5K | +109% | $0 |
| D | 2023-01-09 | 2023-01-05 | OFIX | Elting Kimberley A. | Pres, Gbl Orthopedics | A - Grant | $0.00 | +84.6K | 84.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 35,129 | $0.00 | 140,924 | D | — | — | (F1) The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. |
| 2 | Common | Common Stock | 2023-01-05 | A | A | 20,492 | $0.00 | 185,179 | D | — | — | (F4) Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025. |
| 3 | Common | Common Stock | 2023-01-05 | A | A | 12,229 | $0.00 | 164,687 | D | — | — | (F3) Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024. |
| 4 | Common | Common Stock | 2023-01-05 | A | A | 11,534 | $0.00 | 152,458 | D | — | — | (F2) Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-05 | A | A | 84,566 | $0.00 | 84,566 | D | $20.90 · — to 2033-01-05 | 84,566 Common Stock | (F5) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. |